![Byung-Ho Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 12 474 $ al 30/06/2026
Byung-Ho Lee currently works at MedPacto, Inc., as Auditor from 2022 and Russell Co., Ltd., as Auditor from 2019.
Dr. Lee received his doctorate degree from Georgia Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDPACTO, INC. 0,02 % | 31/12/2024 | 6.145 ( 0,02 % ) | 12 474 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RUSSELL CO., LTD. | Comptroller/Controller/Auditor | 26/07/2019 |
| MEDPACTO, INC. | Comptroller/Controller/Auditor | 28/03/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Russell Co., Ltd.
 Russell Co., Ltd. Industrial MachineryProducer Manufacturing Manufactures and supplies semiconductor machinery & equipment | Producer Manufacturing |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
